The Head of HALMED held a lecture at the DIA conference “Development, innovation affordability and patient safety”
13.04.2015
The Head of the Agency for Medicinal Products and Medical Devices (HALMED), Dr Viola Macolić Šarinić, MD, PhD participated today, together with representatives from the relevant European bodies in the field of medicines, at the roundtable organised within the conference entitled "Development, innovation, affordability and patient safety”. The conference is organised by Drug Information Association (DIA) in Paris from 13 to 15 April 2015.
At the roundtable discussion dedicated to the fiftieth anniversary of the EU pharmaceutical legislation, the HALMED Head held, together with Xavier De Cuyper, CEO of the Belgian Federal Agency for Medicines (AFMPS) a lecture on the scientific contribution of the EMA committees and network of national experts for medicines.
Other representatives of the relevant bodies of the EU regulatory network for medicines also took part at the round table discussion; Guido Rasi, principal advisor at the EMA, Andrzej Ryś, representative of tge DG SANCO, Christoph Thalheim, international director of the European Platform for Multiple Scleroses (EMSP) and Christa Wirthummer-Hoche, the Head of the Austrian Medicines Agency (AGES).
Further to this conference, the Head of HALMED will participate at the panel discussion on opportunities related to reclassification status of medicines from prescription to non-prescription.
